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On the mechanism of diminished urinary carbon dioxide tension caused
by amiloride. We investigated under both in vivo and in vitro conditions
the mechanism whereby amiloride administration, a model of distal
renal tubular acidosis in dogs, decreases the urine-to-blood Pco2
gradient (U-B Pco2) in alkaline urine. The results demonstrate that U-B
Pco2 is reduced in amiloride-treated dogs as previously reported in rats.
The reduction in U-B Pco2 could not be attributed to arniloride-induced
reductions in urinary HCO concentration since the reduction in U-B
Pco2 was observed over the same range of urinary HCO concentra-
tions (150 to 250 mEq per liter) as that achieved prior to amiloride
administration. U-B Pco2 correlated positively and linearly with urinary
HCO3 concentration both prior to (P < 0.001) and during amiloride
infusion (P < 0.001). Amiloride administration significantly decreased
the slope (MU-B Pco2J/[HCOfl) of the regression line (P <0.005).
The possibility that amiloride might lower urine Pco2 by catalyzing
intraluminal dehydration of H2C03 was excluded by demonstrating that
amiloride does not possess carbonic anhydrase activity. The additional
possibility that amiloride might facilitate dissipation of carbon dioxide
gradients through diffusion (as reported for carbonic anhydrase) was
excluded by in vitro studies of the effect of amiloride on carbon dioxide
diffusion. These findings suggest that the U-B Pco2 lowering effect of
amiloride is not caused by alterations in urinary [HCOfl, CO2 diffusibil-
ity, or alterations in the dehydration rate of H2C03 thereby providing
strong support for the interpretation that reductions in U-B Pco2 during
amiloride administration represent an impairment in distal nephron
hydrogen ion secretion.
Sur le mechanisme de Ia diminution de Ia pression partielle de carbonique
dans I'urine déterminée par I'amiloride. Nous avons examine in vivo et in
vitro le mecanisme par lequel l'administration d'amiloride, un modèle
d'acidose tubulaire distale chez le chien, diminue le gradient urinesang
de Pco2 (U-B Pco2) en urine alcaline. Les résultats démontrent que U-B
Pco2 est réduit chez le chien traité par l'amiloride comme cela a été
antérieurement montré chez le rat. Le diminution de U-B Pco2 ne peut
pas étre attribuée a Ia diminution de Ia concentration urinaire de HCO
déterminée par l'amiloride puisque Ia diminution de U-B Pco2 a été
observée pour le méme éventail de concentrations urinaires de HCO3
(150 a 250 mEq par litre) que celui realise avant l'administration
d'amiloride. U-B Pco2 est corrélé linéairement et positivement a Ia
concentration urinaire de HCO aussi bien avant (P < 0,001) que
pendant Ia perfusion d'amiloride (P < 0,001). L'administration d'amilo-
ride diminue régulièrement Ia pente ([U-B Pco2]/[HCO lu) de Ia
droite de regression (P < 0,005). La possibilite que l'amiloride puisse
diminuer Ia Pco2 urinaire en catalysant Ia déshydratation intraluminale
de H2C03 a été exclue par Ia demonstration de l'absence d'activite de
type anhydrase carbonique de l'amiloride. La possibilité que l'amiloride
puisse faciliter Ia dissipation par diffusion des gradients de carbonique a
Received for publication March 2, 1981
and in revised form May 25, 1981
0085-2538/82/0021-0008 $01.20
© 1982 by the International Society of Nephrology
été exclue par des etudes in vitro. Ces constatations suggerent que
l'effet de l'amiloride de diminution de U-B Pco2 n'est pas lie a des
modifications de 1HCO I de l'urine, de Ia diffusibilité du carbonique,
ou du debit de déshydratation de H2C03, et par consequent constituent
un argument fort en faveur d'une alteration de La secretion distale d'ion
hydrogéne.
When mammalian urine is alkalinized (pH > 7.8) in physio-
logical response to systemic alkali loads, urine CO2 tension
normally exceeds that in blood. Urine Pco2 normally correlates
positively with urine bicarbonate concentration. Until recently,
the urine-to-blood (U-B) Pco2 gradient was considered to be the
exclusive consequence of hydrogen ion secretion into bicarbon-
ate rich luminal fluid: Carbonic acid, generated from the
reaction of secreted H and luminal HCO dehydrates in post-
papillary urine to increase urine Pco2. The observed direct
relation between urine Pco2 and HCO concentration is attrib-
uted to modulation of the rate of hydrogen ion secretion in the
distal nephron by luminal HCO concentration as the latter is
influenced by the rate of water reabsorption and distal HCO
delivery [1, 2]. The rate of distal hydrogen ion secretion
increases as luminal HCOconcentration increases presumably
because the transepithelial hydrogen ion concentration gradient
opposing hydrogen ion secretion decreases [1, 3]. Failure of
urine Pco2 to increase normally during alkali loading has been
interpreted as evidence of subnormal distal nephron hydrogen
ion secretion [1, 4—6].
Recently, Arruda et a! [71 have questioned the dominant role
of hydrogen ion secretion in determining the urine-to-blood
Pco2 gradient in alkaline urine. Evidence was provided that
large positive values of urine minus blood Pco2 (U-B Pco2) may
be achieved solely as a result of physicochemical properties of
concentrated bicarbonate solutions. During alkali administra-
tion, as urine bicarbonate concentration increases as a conse-
quence of water reabsorption and possibly bicarbonate secre-
tion, carbon dioxide and COç might be generated by the
reaction: HCO + HCO—* CO2 + CO + H20 (the "ampho-
lyte" property of bicarbonate). In vitro experiments demon-
strated that Pco2 values greater than blood occur at bicarbonate
concentrations greater than 120 mEq per liter, a concentration
commonly exceeded in the urine during systemic alkali loading.
Whereas it is possible that both hydrogen ion secretion and
the ampholyte effect might contribute to the normally observed
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positive values of U-B Pco2 in alkaline urine, it has not been
ascertained to what extent these 2 separate processes might
contribute to the final urine Pco2 values [1, 61. Experimental
maneuvers or pathological conditions which decrease U-B Pco2
without alteration in urine bicarbonate concentration have been
interpreted as indicative of impaired distal nephron hydrogen
ion secretion [4, 8, 91. However, interpretation of observed
values of urine Pco2 is further complicated by the possibility of
physiological variability in the dissipation of carbon dioxide
regardless of the mechanism of the origin. In order to interpret
an experimentally induced reduction in U-B Pco2 at a given
urine bicarbonate concentration as indicative of a reduction in
distal nephron hydrogen ion secretion, the possibility must be
excluded that the experimental maneuver does not facilitate
diffusion of carbon dioxide from tubular fluid and postpapillary
urine. Precedent for this possibility is the observation that the
enzyme carbonic anhydrase augments diffusional loss of carbon
dioxide from aqueous solution in vitro [10].
In addition to reduced distal nephron hydrogen ion secretion
and dissipation of carbon dioxide gradients by diffusion, a third
mechanism must be considered in interpreting a reduction in
U-B Pco2, namely, accelerated removal of intraluminal carbon-
ic acid [11]. Intraluminal and postpapillary generation of urine-
to-blood Pco2 gradients occurs as the dehydration of carbonic
acid proceeds toward equilibrium. Accelerated removal of
intraluminal carbonic acid, such as by increased back-diffusion
or dehydration to carbon dioxide and water, might result in
sufficient reduction in carbonic acid concentration in the distal
nephron to preclude the normal luminal or postpapillary genera-
tion of carbon dioxide.
Our observations were designed to further investigate the
mechanism of reduction of U-B Pco2 following amiloride ad-
ministration, a model of distal renal tubular acidosis in dogs
[12]. Our studies indicate that U-B Pco2 is reduced in amiloride-
treated dogs as previously reported in rats [13]. The results
suggest that the U-B Pco2-lowering effect is not caused by
alterations in urinary [HCOfl, carbon dioxide diffusibility, or
alterations in the degradation rate of H2C03 thereby providing
strong support for the interpretation that reductions in U-B
Pco2 during amiloride administration represent an impairment
in distal nephron hydrogen ion secretion.
Methods
In vivo studies in dogs: Effect of acute amiloride administra-
tion on urinary Pco2-generating ability in bicarbonate-loaded
dogs (N = 3). The objective of this protocol was to evaluate the
urinary Pco2-generating ability in dogs before and after acute
amiloride administration. To eliminate the effects of fluctua-
tions in endogenous mineralocorticoid hormone activity, these
studies were performed during chronic DOC (DOCA, Organon,
West Orange, New Jersey) administration (7.5 mg DOC in
sesame oil twice daily, i.m. for 5 days preceding study.) Each
animal was prefed (5 days) a constant amount (30 g/kg per day)
of a low electrolyte synthetic diet [14] homogenized with
distilled water (60 mI/kg) and supplemented with potassium, 5.0
mEq/kg per day as the neutral phosphate salt and chloride, 5.0
mEq/kg per day as either the sodium salt or a mixture of sodium
and potassium. Dogs that failed to eat spontaneously were tube
fed.
The studies were performed on fasting, conscious trained
dogs (17 to 25 kg) in which indwelling catheters were placed in
each of 2 forearm veins, a femoral artery, and the urinary
bladder during a 10 to 15-mm period of thiopental anesthesia.
DOC, 15 mg i,m., was administered on the morning of study 3
hours prior to specimen collection. Urine was collected under
mineral oil from the indwelling bladder catheter. To achieve
high values of urinary bicarbonate concentration, we acutely
increased the arterial plasma bicarbonate concentration to
values greater than 35 mEq per liter by an intravenous priming
dose of a solution composed of 0.14 M NaHCO3 and 0.56 M
KHCO3 given over a 90-mm period. This dose was followed by
a maintenance infusion of 0.688 M NaHCO3 and 0.012 M
KHCO3 at rates of infusion (2 to 4 mi/mm) sufficient to ensure
urinary bicarbonate concentrations in the range of 105 to 250
mEq per liter.
Following 5 consecutive 20-mm urine collection periods,
amiloride (Merck, Sharp and Dohme, West Point, Pennsylva-
nia) dissolved in 0.225% sodium chloride, was administered
intravenously as a ito 4 mg/kg priming infusion over 10 mm and
2 to 10 mg/kg per hr maintenance infusion. The blood volume
sampled (15 ml) was replaced intravenously with a solution
containing 40 mivi NaHCO3 and 105 m sodium chloride.
In vitro studies: Effect of amiloride on the rate of dissipation
of a carbon dioxide gradient generated in vitro. Studies were
carried out in solutions in vitro to investigate the possibility that
amiloride enhanced diffusional loss of carbon dioxide formed by
the "ampholyte" property of concentrated bicarbonate solu-
tions. Because carbonic anhydrase is known to enhance dissi-
pation of elevated carbon dioxide tensions by diffusion in vitro,
this substance was chosen for comparison [10].
Twelve stoppered, 10-mi test tubes containing weighed
amounts of crystalline NaHCO3 were thoroughly evacuated
with a centrifugal vacuum pump. Either amiloride, 2.5 x i0
M, bovine erythrocyte carbonic anhydrase (2500 Wilbur-Ander-
son U/mg protein, Sigma, St. Louis, Missouri) 1 mg/mI, or
distilled water was added to each of 4 tubes. The final NaHCO3
concentration was calculated to be 300 m. The tubes were
placed in a thermostated shaker bath (37° C) for 20 mm, and I-
ml samples were anaerobically aspirated in random order at
time zero into plastic syringes with a 20-gauge needle through
the rubber stopper for analysis of Pco2 and pH. The tubes were
immediately unstoppered after aspiration of the initial sample,
and agitation was continued for an additional 100 mm. Addition-
al samples were anaerobically aspirated from each unstoppered
tube at 20, 40, 60, 80, and 100 mm.
Effect of amiloride on Pco2 of HCO-enriched urine in vitro.
Additional studies were carried out using dog urine in vitro in
place of artificial solutions to investigate the carbon dioxide
dissipative effects of amiloride in normal dog urine. Sixteen
milliliters of urine (pH, 8.1) were added to unstoppered flasks
(N = 8) containing 8 ml 0.94 M NaHCO3 and either I ml of
boiled distilled water or 1 ml amiloride stock solution (pH, 8.1)
to yield a final amiloride concentration of 2.5 X l0 M.
Additional experiments were performed in which the volume of
urine was 20 ml and the volume of NaHCO3 solution was 4 ml
(N = 8). The open flasks (N = 16) were placed in a thermostat-
ed shaker bath at 37° C for 20 mm, at which time aliquots were
aspirated anaerobically into plastic syringes for analysis of Pco2
and total carbon dioxide.
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Carbonic anhydrase activity of amiloride in urine. To investi-
gate the potential for amiloride to lower urine Pco7 by virtue of
carbonic anhydrase activity, we measured carbonic anhydrase
activity of urine containing amiloride by the pH-stat titration
method of Alsen and Ohnesorge [151 at 2° C. This technique
quantitates carbonic anhydrase activity by measurement of the
initial rate of carbon dioxide hydration. Quadruplicate determi-
nations were performed on each of 4 control dog urine samples
and again in the same 4 urine samples to which either amiloride
(2.5 X i0 M) or bovine erythrocyte carbonic anhydrase (1 p,g/
ml) was added.
Analytical procedures. All determinations were performed in
duplicate unless otherwise specified. Analytical methods uti-
lized in this laboratory have been previously reported [16]. For
in vitro studies, pH and Pco2 were determined with a Corning
model 175 blood gas analyzer. Where appropriate, statistical
significance was determined by linear regression analysis, co-
variance analysis, and Student's t test [17].
Results
In vivo studies in dogs: Effect of acute amiloride administra-
lion on urine Pco2 in bicarbonate loaded dogs (N = 3). During
intravenous sodium bicarbonate administration, urinary bicar-
bonate concentrations ranged from 160 to 240 mEq per liter and
were similar prior to and during superimposed intravenous
amiloride administration (Fig. 1). Urine minus blood Pco2
correlated positively and linearly with urinary bicarbonate
concentration both prior to (P < 0.001) and during amiloride
infusion (P < 0.001). Amiloride administration significantly
decreased the slope ([U-B Pco2J/[HCO3}) of the regression
line (P < 0.005). Mean plasma bicarbonate concentration,
Paco2, and blood hydrogen ion concentration were not signifi-
cantly different prior to and during amiloride administration
(42.8 1.1 vs. 46.9 2.5 mEq per liter; 46.9 1.0 vs. 42.2
5.3 mm Hg; and 27 I vs. 22 4 nEq per liter, respectively).
When the values of U-B Pco2I[HC05 ],, following amiloride
administration were compared only within the range of values
of blood [HI observed prior to amiloride administration (23 to
31 nEq per liter), a significant difference in U-B Pco2I[HCO3 1,
was observed (U-B Pco2/[HCO] 0.060 0.004 vs. 0.125
0.010, P < 0.001; blood [H] 26.5 0.9 vs. 27.1 0.4 nEq per
liter, P > 0.40). Thus the observed alterations in U-B Pco,
following amiloride administration are not attributable to alter-
ations in systemic acid-base equilibrium [181.
In vitro studies: Effect of' amiloride on the rate of dissipation
of a carbon dioxide gradient generated in vitro. The time course
of carbon dioxide dissipation in control bicarbonate solutions
and those containing amiloride and carbonic anhydrase is
shown in Figure 2. The decrease in solution Pco2 was substan-
tially more rapid in solutions containing carbonic anhydrase
than in control or amiloride-containing solutions. No apprecia-
ble difference in the rate of carbon dioxide dissipation was
detected between control and amiloride solutions.
Effect of amiloride on Pco2 of HCOenriched urine in vitro.
The addition of amiloride in vitro to bicarbonate-enriched urine
did not increase carbon dioxide losses during exposure to room
air (Fig. 3).
Carbonic anhydrase activity of amiloride in urine. As depict-
ed in Table 1, urine containing bovine erythrocyte carbonic
anhydrase demonstrated significant carbonic anhydrase activi-
I I I
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Fig. 1. Effect of amiloride administration in DOC-treated bicarbonate-
loaded dogs on in vivo urine ,ninus blood Pco2. The linear regression
equation for the DOC period is y = —57.2 + O.4l and for the DOC +
amiloride period is y = —29.6 + O.20.
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Fig. 2. Effect of amiloride and carbonic anhydrase on the rate of in vitro
carbon dioxide dissipation from aqueous solution. Carbon dioxide
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Fig. 3. Effect of amiloride on urine Pco2 in alkaline urine in vitro.
ty. Urine containing amiloride demonstrated no appreciable
carbonic anhydrase activity.
Discussion
Amiloride is a clinically-utilized, diuretic agent of moderate
natriuretic potency by comparison with ethacrynic acid, furose-
mide, and benzothiadiazine diuretics. The results of micropunc-
ture studies in rats [19] and stop-flow studies in dogs [20] were
interpreted as indicating that the effect of amiloride on sodium
transport is localized to the distal nephron. Studies in isolated
perfused segments of rabbit cortical tubules demonstrate an
effect of amiloride to diminish transtubular electrical potential
difference in the distal convoluted tubule and collecting tubule
[2 1—251, to diminish sodium and bicarbonate reabsorption and
potassium secretion in collecting tubule [23, 25], and to inhibit
the sodium reabsorptive and potassium secretory responses to
exogenous mineralocorticoid in the collecting tubule [25]. The
recent finding in bicarbonate-loaded rats that amiloride reduced
U-B Pco2 without significant reduction in urine bicarbonate
concentration has been interpreted as evidence that amiloride
inhibits hydrogen ion secretion in the distal nephron [131.' In
'It is conceivable that amiloride administration might reduce U-B
Pco2 as a result of inhibition of bicarbonate reabsorption in the
proximal tubule [26], although no known pathophysiological mecha-
nism has been described to link alterations in proximal bicarbonate
reabsorption with alterations in U-B Pco2 for a given urinary bicarbon-
ate concentration. Furthermore, it has been demonstrated that inhibi-
tion of proximal bicarbonate reabsorption induced by lysine administra-
tion does not result in reductions in U-B Pco2 [27].














B 1.21 1.25 7.01
C 1.37 0.95 7.13
D 0.98 0.99 6.63
Mean 1.13 1.01 6.86**
Values for each urine specimen represent the mean of quadruplicate
titrations. Carbonic anhydrase activity is measured by the pH-stat
method as the rate of carbon dioxide hydration (rate of NaOH addition
at constant pH). Mean values for amiloride and carbonic anhydrase-
containing urine samples were tested for significant differences from
control and are footnoted * and ** indicative of significance at the
0.05 and 0.001 probability levels, respectively (Student's t test).
dogs but not in rats the acidification defect is of sufficient
magnitude to result in sustained metabolic acidosis [12, 13].
In the present study of bicarbonate-loaded dogs, the finding
that amiloride administration reduced U-B Pco2 over a wide
range of urine bicarbonate concentrations provides evidence in
an additional species that the urine Pco2-lowering effect of
amiloride is not the consequence of a reduction in the urine
bicarbonate concentration [13]. Prior to amiloride administra-
tion, the values of urine Pco2 observed during bicarbonate
loading were not greater than those predicted by the ampholyte
property of bicarbonate in highly concentrated solutions Fl, 7].
If urine Pco2 is decreased significantly in the absence of change
in the urine bicarbonate concentration, then it may be inferred
that some factor in addition to the ampholyte effect must have
contributed to the observed U-B Pco2 gradient.
The role of the urinary concentrating mechanism in the
genesis of high values of U-B Pco2 in alkaline urine remains
unresolved. A recent analysis has suggested that water abstrac-
tion alone would not result in de novo generation of carbon
dioxide by the ampholyte effect in the distal nephron, because
water abstraction, alone, would not concentrate luminal bicar-
bonate to a greater extent than carbon dioxide, as would be
required for carbon dioxide to be generated by the ampholyte
property of bicarbonate [1]. But this analysis does not exclude
the possibility that the direct carbon dioxide concentrating
effect of water abstraction is sufficient to generate the directly-
measured values of U-B Pco2 inasmuch as the Pco2 gradient is
developed to a significant extent within the collecting duct
lumen where water abstraction occurs [28]. However, it is
unlikely that urinary concentration plays a critical role in the
generation of high values of urine carbon dioxide because
significant U-B Pco2 gradients have been observed during alkali
loading under conditions of maximal water diuresis [29, 30].
It is conceivable that amiloride-induced inhibition of bicar-
bonate secretion is responsible for the observed difference in U-
B Pco2 over a wide range of the urine bicarbonate concentra-
tion and that the difference in U-B Pco2 represents carbon
dioxide generated from the ampholyte effect of secreted bicar-
bonate. Evidence against a major role for amiloride to inhibit
bicarbonate secretion in our studies is the reported effect of
amiloride to increase bicarbonate secretion in collecting tubules
in rabbits [24].
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In summary, the results of our studies suggest that the U-B
Pco2 lowering effect of amiloride is not caused by alterations in
urinary bicarbonate concentration, enhancement of carbon
dioxide diffusibility, or a carbonic anhydrase-like catalytic
effect. The results, therefore, support the interpretation that
reductions in U-B Pco2 during amiloride administration repre-
sent an impairment in distal nephron hydrogen ion secretion.
Acknowledgments
We thank Russell White, Maureen McTigue. Jane Heaney, and Jon
Siiteri for their technical assistance and Lois Deenihan for typing the
manuscript. These experiments were supported by Grant SF76-63,
Public Health Service. Central Clinical Investigation Committee, and
National Institutes of Health grants RR-00079, AM-2 1605, and AM-
28643.
Reprint requests to Dr. H. N. Flu/icr, General Clinical Research
Center, 1202 Mofflut, University ofCalifornia, San Francisco, Califor-
nia 94143, USA
21t might he argued that finding amiloride did not enhance dissipation
of carbon dioxide gradients in vitro makes it unnecessary to determine
whether amiloride possesses carbonic anhydrase-like activity in viva.
Based on currently available information, carbonic anhydrase activity
increases carbon dioxide diffusivity in vitro by increasing the rate of
carbon dioxide formation throughout the solution, thereby increasing
escape at the gas-liquid interface 1311. However, this mechanism would
not appear to account for the facilitation of transmembrane carbon
dioxide transport by membrane-bound carbonic anhydrase in washed
erythrocyte ghosts, which suggests the possibility that carbonic anhy-
drase-mediated facilitation of transmemhrane carbon dioxide transport
in living cells may occur by a different mechanism than that in bulk
solutions [311. Thus, membrane-bound amiloride in the collecting duct
might conceivably alter the apparent permeability of the cell membrane
to carbon dioxide or H2C03. Although the structure of amiloride bears
no relation to that of the enzyme carbonic anhydrase, it is recognized
that low molecular weight, non-enzymatic catalysts of carbonic acid
dehydration exist that are structurally dissimilar to carbonic anhydrase,
and certain of these catalysts (for example, imidazole) bear structural
similarity to amiloride [32, 33]. Hence, the possibility cannot be
excluded that membrane-bound amiloride in the collecting duct might
facilitate the transport of carbon dioxide (or H2C03) thereby contribut-
ing to a reduction in U-B Pco2.
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